CLC Number: 

  • R742
[1] Algahtani H, Shirah B, Alassiri A. Tumefactive demyelinating lesions: A comprehensive review[J]. Mult Scler Relat Disord, 2017, 14: 72-79. doi: 10.1016/j.msard.2017.04.003.
[2] Liao PY, Chen CY. Regarding tumefactive demyelinating lesion, its image diagnosis, and discussion[J]. Am J Emerg Med, 2015, 33(2): 290-291.
[3] 张伟华,董丽丽,张斌升,等. 中枢神经系统炎性脱髓鞘性假瘤一例报道[J]. 中华神经医学杂志,2019,18(3): 293-296. ZHANG Weihua, DONG Lili, ZHANG Binsheng, et al. A case report of inflammatory demyelination pseudotumor of central nervous system[J]. Chinese Journal of Neurology, 2019, 18(3): 293-296.
[4] Tremblay MA, Villanueva-Meyer JE, Cha S, et al. Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions[J]. J Neurol Sci, 2017, 381: 83-87. doi: 10.1016/j.jns.2017.08.015.
[5] Algahtani H, Shirah B, Alassiri A. Tumefactive demyelinating lesions: A comprehensive review[J]. Mult Scler Relat Disord, 2017, 14: 72-79. doi: 10.1016/j.msard.2017.04.003.
[6] 姜京超,吕玉玲,彭龙锋,等. 脑内脱髓鞘假瘤二例并文献复习[J]. 海军医学杂志,2016,37(6): 585-587. JIANG Jingchao, LYU Yuling, PENG Longfeng, et al. Two cases of demyelination pseudotumor in the brain and literature review[J]. Journal of Naval Medicine, 2016, 37(6): 585-587.
[7] 阎守芳,高慧,钟文新,等. MRI诊断中枢神经系统炎性脱髓鞘性假瘤的价值[J]. 中国CT和MRI杂志,2018,16(9): 61-63. YAN Shoufang, GAO Hui, ZHONG Wenxin, et al. Diagnostic value of MRI in inflammatory demyelination pseudotumor of central nervous system[J]. Chinese Journal of CT and MRI, 2016, 16(9): 61-63.
[8] Preziosa P, Martinelli V, Moiola L, et al. Dynamic pattern of clinical and MRI findings in a tumefactive demyelinating lesion: a case report[J]. J Neurol Sci, 2016, 361: 184-186. doi: 10.1016/j.jns.2015.12.039.
[9] de Medeiros FC, de Albuquerque LA, Pittella JE, et al. Open-ring enhancement in pseudotumoral multiple sclerosis: important radiological aspect[J]. Case Rep Neurol Med, 2014, 2014: 951690. doi: 10.1155/2014/951690.
[10] 刘建国,董秦雯,张海玲,等. 病理证实的瘤样脱髓鞘病60例影像学特点[J]. 中华神经科杂志,2014,47(10): 680-686. LIU Jianguo, DONG Qinwen, ZHANG Hailing, et al. Imaging characteristics of 60 pathologically confirmed cases of tumorlike demyelination[J]. Chinese Journal Neurology, 2014, 47(10): 680-686.
[11] Ikeguchi R, Shimizu Y, Abe K, et al. Proton magnetic resonance spectroscopy differentiates tumefactive demyelinating lesions from gliomas[J]. Mult Scler Relat Disord, 2018, 26: 77-84. doi: 10.1016/j.msard.2018.08.025.
[12] Law M, Meltzer DE, Cha S. Spectroscopic magnetic resonance imaging of a tumefactive demyelinating lesion[J]. Neuroradiology, 2002, 44(12): 986-989.
[13] Saindane AM, Cha S, Law M, et al. Proton MR spectroscopy of tumefactive demyelinating lesions[J]. AJNR Am J Neuroradiol, 2002, 23(8): 1378-1386.
[14] Davie CA, Hawkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions[J]. Brain, 1994, 117( Pt 1): 49-58.
[15] Naik S, Bhoi SK, Agarwal V, et al. Perfusion MRI may facilitate the diagnosis of a tumefactive demyelinating lesion[J]. Neurol India, 2019, 67(3): 908-910.
[16] Parks NE, Bhan V, Shankar JJ. Perfusion imaging of tumefactive demyelinating lesions compared to high grade gliomas[J]. Can J Neurol Sci, 2016, 43(2): 316-318.
[1] YAN Chuanzhu, WANG Wei, JI Kunqian, ZHAO Yuying. Mitochondrial dysfunction and related brain diseases [J]. Journal of Shandong University (Health Sciences), 2020, 58(8): 34-41.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!